Tag: Alzheimer’s

1. In these two randomized parallel-group trials, the use of gantenerumab did not lead to slower cognitive decline over 116 ...

1. In this randomized controlled trial, over a period of 240 weeks, solanezumab did not slow cognitive decline as compared ...

The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. ...

1. In this meta-analysis, it was found that the pooled prevalence of sleep-related breathing disorders (SRBDs) among dementia patients was ...

1. In this retrospective cohort study, there was an increased prevalence of age-, race-, and body mass index (BMI)-adjusted cardiovascular, ...

1. Lecanemab was associated with reduced amyloid markers in early Alzheimer’s disease as compared to placebo. 2. Lecanemab also resulted ...

1. In this randomized controlled trial, among 457 participants with prodromal to mild Alzheimer’s disease, semorinemab was not shown to ...

1. Physical activity was significantly associated with a decreased incidence of all-cause dementia and Alzheimer’s disease, irrespective of follow-up length, ...

1. Physical activity was significantly associated with a decreased incidence of all-cause dementia and Alzheimer’s disease, irrespective of follow-up length, ...